Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: Prospective cohort study of a nationwide programme in the Netherlands

Prenatal Fetal DNA Testing for Predicting HDFN, FNAIT, and RhIG Candidacy

Fetal RHD typing can be safely used to target both antenatal and postnatal anti-D prophylaxis